argenx SRL
510.9 FTEargenx reported revenue of €3.80bn for the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026), with 510.9 full-time equivalents.
The score of argenx shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +701 % Equity +115 % Total assets +120 % Headcount (avg FTE) +59 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
argenx's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €3.80bn | ||||
| Net result | €1.38bn | ||||
| Equity | €5.71bn | ||||
| Cash | €2.97m | ||||
| EBITDA | €2.48bn | ||||
| Total assets | €7.01bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jun 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
argenx's financial analysis
- Solvency81.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of argenx
argenx's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0818.292.196
- VAT number
- BE0818292196
- Peppol
- Registered · 0208:0818292196 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Sep 2009
- Registered office
- 9052 Ghent
- Size
- Large · 510.9 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
argenx (SRL) has been based in Ghent since 2009, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €3.80bn, a net profit of €1.38bn and equity of €5.71bn. With 510.9 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 81.4%, above the median of its sector (60.4%).
Companies similar to argenx
Companies in the same business, of comparable size and area, outside its group.
- UCB Biopharma Manufacture of pharmaceutical preparations Anderlecht · balance sheet €7.15bn
- Lakefront Biotherapeutics Research and experimental development on natural sciences and engineering Mechelen · balance sheet €3.34bn
- Genzyme Flanders Manufacture of pharmaceutical preparations Geel · balance sheet €1.00bn
- UCB Developed Brands Research and experimental development on natural sciences and engineering Anderlecht · balance sheet €1.07bn
- Ablynx Research and experimental development on natural sciences and engineering Ghent · balance sheet €417.3m
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
- CellCarta Biosciences Research and experimental development on natural sciences and engineering Charleroi · balance sheet €22.4m
Frequently asked questions about argenx
What is the revenue of argenx?
According to the 2025 annual accounts filed with the NBB, the revenue of argenx amounts to 3,795,543,211 €.
What is the VAT number of argenx?
In Belgium, the VAT number is the company number prefixed with BE: BE0818292196 for argenx, if the company is VAT-registered. Its company number (CBE) is 0818.292.196.
Where is the registered office of argenx?
According to the CBE register, the registered office of argenx is in 9052 Ghent.
What is the equity of argenx?
At the close of the 2025 financial year, the equity of argenx amounts to 5,705,241,767 €, a solvency of 81.4% of total assets.
How many people work at argenx?
510.9 full-time equivalents on average according to the 2025 social balance sheet.
Who manages argenx?
The register lists 3 active mandates at argenx. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of argenx
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →